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ABSTRACT

Using mass spectrometry, we identified p190RhoGAP (p190) as a binding partner of human papillomavirus 16 (HPV16) E7. p190
belongs to the GTPase activating protein (GAP) family and is one of the primary GAPs for RhoA. GAPs stimulate the intrinsic
GTPase activity of the Rho proteins, leading to Rho inactivation and influencing numerous biological processes. RhoA is one of
the best-characterized Rho proteins and is specifically involved in formation of focal adhesions and stress fibers, thereby regulating cell migration and cell spreading. Since this is the first report that E7 associates with p190, we carried out detailed interaction
studies. We show that E7 proteins from other HPV types also bind p190. Furthermore, we found that conserved region 3 (CR3)
of E7 and the middle domain of p190 are important for this interaction. More specifically, we identified two residues in CR3 of
E7 that are necessary for p190 binding and used mutants of E7 with mutations of these residues to determine the biological consequences of the E7-p190 interaction. Our data suggest that the interaction of E7 with p190 dysregulates this GAP and alters the
actin cytoskeleton. We also found that this interaction negatively regulates cell spreading on a fibronectin substrate and therefore likely contributes to important aspects of the HPV life cycle or HPV-induced tumorigenesis.
IMPORTANCE

H

uman papillomaviruses (HPVs) are small, double-stranded
DNA viruses which induce papillomas in cutaneous and mucosal epithelia and are also the etiological agents of many cervical
and other anogenital cancers (1–5). More than 150 HPV types
have been described, and many more are presumed to exist (6).
Specific HPV types often preferentially infect distinct anatomical
sites. HPVs associated with lesions that can progress to carcinogenesis are classified as “high-risk” types, the most common of
which is HPV16. In contrast, HPVs associated with benign warts
that regress with time are termed “low-risk” viruses (7).
The ability of HPVs to induce cellular immortalization and
transformation is attributed primarily to the viral oncoproteins E6
and E7, which are consistently expressed in HPV-induced cancers
(8–11). While E6 prevents apoptosis by inducing the degradation
of the tumor suppressor p53 through the proteasome system, E7
disrupts cell cycle regulation by binding and inactivating the retinoblastoma tumor suppressor (pRb) (12, 13). In addition, both
E6 and E7 alter other cellular signaling pathways by interacting
with a plethora of cellular proteins and dysregulating their function, thereby enhancing the carcinogenic potential of the cell (14–
19). To date, E7 has been reported to interact with over 50 cellular
factors, although the biological significance of many of these interactions is unknown (20).
Here we demonstrate a novel interaction of HPV E7 with
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p190RhoGAP (p190), a Rho family GTPase activating protein
(GAP). p190 belongs to a large family of proteins that stimulate
the intrinsic GTPase activity of the Rho proteins, leading to Rho
inactivation. Rho family GTPases serve as molecular switches, cycling between active, GTP-bound and inactive, GDP-bound states
and transducing signals from the extracellular environment to
elicit cellular responses such as changes in gene expression, morphology, and migration (21, 22). Of the known Rho proteins,
Cdc42, Rac1, and RhoA are the most thoroughly characterized
(23). The ability of Rho GTPases to associate with downstream
effectors is held in balance by the opposing activities of guanine
nucleotide exchange factors (GEFs), which encourage GTP loading, and GAPs, which catalyze the low-level GTPase activity of
Rho (24). Precise spatial and temporal regulation of Rho family
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This study identifies p190RhoGAP as a novel cellular binding partner for the human papillomavirus (HPV) E7 protein. Our
study shows that a large number of different HPV E7 proteins bind p190RhoGAP, and it identifies regions in both E7 and
p190RhoGAP which are important for the interaction to occur. This study also highlights the likelihood that the E7p190RhoGAP interaction may have important biological consequences related to actin organization in the infected cell. These
changes could be an important contributor to the viral life cycle and during progression to cancer in HPV-infected cells. Importantly, this work also emphasizes the need for further study in a field which has largely been unexplored as it relates to the HPV
life cycle and HPV-induced transformation.

proteins is critical for numerous cellular processes; for instance,
RhoA is crucial for efficient cell migration and cell spreading, and
while some RhoA activity is required for migration, possibly to
maintain sufficient adhesion to the substrate, high RhoA activity
inhibits movement (25).
Through Rho-dependent and Rho-independent functions,
p190 plays a critical role in regulating actin cytoskeleton dynamics
and cell spreading; it also negatively controls tumor growth, transformation, metastasis, invasion, and angiogenesis, strongly suggesting that p190 may function as a tumor suppressor (26–31).
Therefore, p190 appears to be an attractive target for a viral oncoprotein such as HPV E7. In this study, our aim was to characterize
the interaction of E7 with p190 at the biochemical level and to
determine the biological consequences of this association. We
show that the C-terminal region of E7 is necessary and sufficient to
associate with p190. Using a panel of surface-exposed mutants in
the C terminus of E7, we identified two mutants unable to bind
p190. Utilizing these two mutants of E7 and a dominant negative
mutant of p190 as tools to probe the biological significance of the
interaction, we first demonstrate that E7 binding to p190 contributes to an altered actin cytoskeleton. In addition, we show that
E7-p190 interaction reduces cell spreading in E7-expressing cells
on a fibronectin substrate.
MATERIALS AND METHODS
Plasmids. The surface-exposed mutants within CR3 of HPV16 E7 were
previously generated by site-directed mutagenesis and are described elsewhere (32). GFP-fused E7 constructs for HPV16, HPV6, HPV11, and
HPV18 were described previously (33). Full-length E7 genes from
HPV31, HPV33, HPV39, HPV45, HPV52, HPV55, HPV58, HPV59,
HPV67, and HPV74 were PCR amplified from the viral genomes and
cloned into the pCANmycEGFP vector by using EcoRI and XbaI restriction sites. The source for HPV genomes and the primer sequences used for
HPV E7 cloning will be provided upon request. Hemagglutinin (HA)tagged p190RhoGAP (p190) full-length and GTP-binding domain (GBD;
amino acids 1 to 266) constructs were kind gifts from S. Parsons (University of Virginia, Charlottesville, VA) and were described previously (34).
p190 MD (amino acids 379 to 1183) and GAP (amino acids 1180 to 1513)
constructs were PCR amplified using the following primers: MD-F, ACT
GTGGATCCTGGTTTGTTGTACTT; MD-R, ACTGTGAATTCTCACA
GCTCATCATCACT; GAP-F, ACTGTGGATCCGATGATGAGCTGGGA;
and GAP-R, ACTGTGAATTCTCAAGAAGACAACTGATT. These constructs were then cloned into the backbone of the pKH3 vector by using
BamHI and EcoRI restriction sites. p190RA is the dominant negative
p190(R1283A) mutant; it was a kind gift from Ian Macara (Vanderbilt
University Medical Center, Nashville, TN).
Cell culture and transfection. Human HaCat, CaSki, C33A, U2OS,
and HT1080 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and
penicillin-streptomycin (100 U/ml). For coimmunoprecipitation experiments, HT1080 cells were seeded into 10-cm plates at 2 ⫻ 106 cells per
plate and transfected 24 h later with 8 g of total DNA using
X-tremeGENE HP (Roche, Laval, Quebec, Canada) according to the
manufacturer’s instructions. At 24 h posttransfection, cells were collected
for coimmunoprecipitation experiments. U2OS cells stably expressing E7
or matched U2OS-neo control cells were obtained from Karl Munger
(Brigham and Women’s Hospital, Boston, MA) and maintained as previously described (35).
Antibodies. For Western blots, rat anti-hemagglutinin (anti-HA)
(Roche) was used at 1:2,000, and for coimmunoprecipitation experiments, 25 l of mouse anti-HA hybridoma lysate (clone 12CA5) was
utilized per sample. Green fluorescent protein (GFP) was detected using
rabbit anti-GFP (Living Colors; Clontech, Mountain View, CA) at
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1:2,000, and E7 was detected using mouse anti-E7 (8C9; Invitrogen, Burlington, Ontario, Canada) at 1:200. myc-tagged constructs were detected
with a mouse anti-myc hybridoma lysate (clone 9E10), used at 1:200.
Monoclonal anti-phosphotyrosine was used at 1:500 (Upstate). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit (Jackson Laboratories, Sacramento, CA), goat anti-rat (Pierce, Rockford, IL), and rabbit
anti-mouse (Jackson Laboratories) were used as secondary antibodies.
Coimmunoprecipitation and Western blot analysis. Cells were
transfected at a 1:1 ratio with the myc-GFP fusion and an HA-tagged
binding partner. Cells were harvested at 24 h posttransfection by scraping
and were washed once with 1⫻ phosphate-buffered saline (PBS). Cells
were lysed in NP-40 (50 mM Tris, pH 7.8, 150 mM NaCl, 0.5% NP-40)
lysis buffer supplemented with 1⫻ mammalian protease inhibitor cocktail (Sigma, Oakville, Ontario, Canada). Typically, 1 mg of cell lysate was
mixed with 100 l of anti-myc hybridoma or 25 l of anti-HA hybridoma
and 100 l of a 10% slurry of protein A-Sepharose resin (Sigma) and
incubated at 4°C for 1 to 2 h on a nutator. Immunoprecipitates were
washed three times with lysis buffer, resuspended in 2⫻ lithium dodecyl
sulfate (LDS) sample buffer, and then boiled for 5 min. Samples were
analyzed by Western blotting. To assess the phosphorylation status of
p190 in E7-expressing cells, U2OS cells were transfected with 2 g of
HA-p190 and 6 g of GFP or GFP-E7. At 48 h posttransfection, the lysates
were prepared in NP-40 lysis buffer and subjected to immunoprecipitation with anti-HA antibody, followed by immunoblotting as indicated.
Immunofluorescence and image analysis. Cells were fixed with 3.7%
formaldehyde for 20 min and then permeabilized with 0.2% Triton X-100
for 20 min at room temperature. Samples were washed extensively with
1⫻ PBS, pH 7.4, and once with 0.1 M glycine (in PBS). The slides were
then incubated with Alexa 568-phalloidin (Invitrogen) at 1:200 (in PBS)
for 1 h at 37°C in a humidity chamber. The slides were washed extensively
with PBS and then mounted on glass slides with ProLong antifade reagent
with DAPI (4=,6-diamidino-2-phenylindole) mounting medium (Invitrogen). Imaging was performed using a Nikon Eclipse Ti-S fluorescence
microscope equipped with a QImaging Retiga 1300-coded monochrome
12-bit camera. Images were captured using Velocity software, version 7.0.
Confocal images were acquired with a Fluoview 1000 laser scanning confocal microscope (Olympus Corp.), using a ⫻60 Plan Apochromat 1.42
oil objective. Multicolor images were acquired in the sequential acquisition mode to avoid cross-excitation. Quantification of phalloidin levels
was carried out using images acquired on the fluorescence microscope
and using ImageJ as previously described (36). Data are representative of
a minimum of 75 cells for each sample.
Cell spreading. Cells were trypsinized at 24 h posttransfection and
washed two times with DMEM without FBS or antibiotics. The cells were
resuspended in DMEM with 0.5% bovine serum albumin (BSA) (fatty
acid free; Sigma) for 1 h at 37°C. Suspended cells were plated onto fibronectin-coated (10 g/ml) coverslips for 20 min and then immediately
fixed and stained with phalloidin as described above. Images were captured with a fluorescence microscope as described above, and cell area was
determined using ImageJ.
RhoGTP assay. Cellular RhoA-GTP was measured using a colorimetric G-Lisa RhoA activation assay kit as suggested by the manufacturer
(Cytoskeleton).

RESULTS

HPV16 E7 associates with p190RhoGAP. We initially observed
that p190 associates with HPV16 E7 by mass spectrometry.
HEK293 cells were transfected with epitope-tagged E7, and lysates
were immunoprecipitated for the epitope tag and analyzed by liquid chromatography–matrix-assisted laser desorption ionization–tandem time of flight (LC-MALDI-TOF/TOF) mass spectrometry (data not shown). This identified p190 with a high
confidence/coverage (84.3% sequence coverage). As an initial step
in confirming this novel binding partner of E7, we utilized two
human cervical cancer cell lines: CaSki cells are HPV16 positive
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and express the E6 and E7 oncoproteins, whereas C33A cells are
HPV negative and served as a negative control. We carried out
coimmunoprecipitation experiments by using anti-E7 antibody,
followed by Western blotting with anti-p190 antibody. This experiment confirmed that p190 associates with E7 under endogenous conditions (Fig. 1).
C-terminal sequences of HPV16 E7 are necessary and sufficient to bind p190RhoGAP. We next identified which regions
within E7 and p190 are important for interaction. First, we utilized coimmunoprecipitation experiments and two fragments of
HPV16 E7 fused to myc-GFP: residues 1 to 39 span the intrinsically disordered conserved region 1 (CR1) and CR2 of E7, whereas
residues 39 to 98 contain CR3 of E7, which is the highly structured
zinc-binding domain. We selected to carry out all transfectionbased mapping studies in human fibrosarcoma HT1080 cells,
since this cell line is transfected exceptionally well using commercially available transfection reagents. We cotransfected HT1080
cells with HA-tagged p190 and the individual myc-GFP-E7 constructs and carried out coimmunoprecipitation experiments using an anti-HA antibody. These experiments revealed that CR3 of
E7 is both necessary and sufficient for interaction with p190 (Fig.
2A). In addition, we carried out these experiments in a reciprocal
manner, immunoprecipitating for E7 and blotting for p190, with
similar results (data not shown). Furthermore, we also mapped
the region of p190 that is sufficient to associate with HPV16 E7.
We utilized three fragments of p190: the GTP-binding domain
(GBD) (residues 1 to 266), the middle domain (MD) (residues 379
to 1183), and the GAP domain (residues 1180 to 1513). Coimmunoprecipitation experiments with E7 residues 39 to 98 revealed
that the middle domain, a region of p190 which is known to contain many protein-protein interaction motifs, is sufficient to associate with E7 (Fig. 2B) (37–39).
HPV16 E7 V55T and R66E mutants do not associate with
p190RhoGAP. We utilized a panel of E7 mutants targeting CR3
residues which are predicted to be solvent exposed (32) to map the
surface of E7 required for p190 interaction. Initially, we cotransfected full-length p190 and each of the 21 individual point mutants of E7 in the context of residues 39 to 98, and we then carried
out coimmunoprecipitation experiments. This approach revealed
that two mutants, the V55T and R66E mutants, completely lost
binding to p190 (Fig. 3A). Furthermore, we confirmed these findings using the V55T and R66E mutants in the context of fulllength E7 (Fig. 3B). Interestingly, based on our previous structural
modeling studies, the V55T and R66E mutants formed a small
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FIG 2 Conserved region 3 (CR3) of HPV16 E7 and the middle domain (MD)
of p190 are sufficient for interaction. (A) CR3 of HPV16 E7 (residues 39 to 98)
is necessary and sufficient to associate with p190. HT1080 cells were transfected with full-length HA-tagged p190 and the indicated GFP or GFP-E7
fusion construct (E7, E7 1–39, and E7 39 –98 are all GFP fusions). At 24 h
posttransfection, cell lysates were prepared and subjected to coimmunoprecipitation as indicated. (B) The middle domain of p190 is sufficient to associate
with E7 (residues 39 to 98). HT1080 cells were transfected with the indicated
HA-tagged p190 constructs and GFP or GFP-E7 39 –98. Samples were subjected to coimmunoprecipitation as indicated.
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FIG 1 HPV16 E7 associates with p190RhoGAP (p190). Lysates from HPV16positive (CaSki) and HPV-negative (C33A) cells were prepared and immunoprecipitated (IP) for E7 as described in Materials and Methods. Samples were
immunoblotted as indicated.

Todorovic et al.

FIG 3 Residues V55 and R66 in HPV16 E7 are required for association with p190. (A) HT1080 cells were transfected with full-length HA-tagged p190 and GFP
or GFP fused to residues 39 to 98 of HPV16 E7 containing the indicated mutations. Coimmunoprecipitation experiments were carried out at 24 h posttransfection, as indicated. (B) HT1080 cells were transfected with full-length HA-tagged p190 and full-length wild-type GFP-E7 or the V55T or R66E mutant, and
samples were processed for coimmunoprecipitation as indicated for panel A.

species 10 viruses HPV6, HPV11, HPV55, and HPV74, high-risk
species 7 viruses HPV18, HPV39, HPV45, and HPV59, and highrisk species 9 viruses HPV16, HPV31, HPV33, HPV52, HPV58,
and HPV67. We carried out coimmunoprecipitation experiments
and found that all tested E7 proteins, except for HPV59, associated
with p190, illustrating that this interaction is highly conserved
(Fig. 4A). In this assay, low-risk species 10 E7 oncoproteins
seemed to recover the most p190. On the other hand, high-risk

FIG 4 The E7 proteins of multiple HPV species interact with p190. (A) E7 proteins from other HPV species and types associate with p190. HT1080 cells were
transfected with HA-tagged p190 and GFP or GFP-E7 fusions, as indicated. At 24 h posttransfection, cell lysates were prepared and subjected to coimmunoprecipitation using anti-HA antibody. The samples were immunoblotted as indicated. (B) Multiple-sequence alignment of HPV E7 CR3 sequences. The residue
numbering indicated on the top line corresponds to HPV16 E7 numbering. Indicated on the left of the alignment are the species and HPV type. Darker shading
corresponds to more highly conserved residues. The positions of residues V55 and R66 are indicated at the top of the alignment (*). The E and Q residues of
species 7 types at the position of R66 (HPV16) are highlighted with a box.
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patch on the surface of E7 CR3 (32, 33). The identification of E7
mutants unable to bind p190 provided us with reagents to study
the significance of the E7-p190 interaction, as described below.
E7 proteins from other HPV types interact with p190. Since
this is the first report illustrating that HPV16 E7 associates with
p190, we next established whether E7 proteins of other HPVs similarly bind p190. For that purpose, we cloned 13 other E7 oncoproteins from their respective genomes. These included low-risk

species 7 E7 proteins, including that of HPV59, invariably recovered the least p190. Interestingly, this low binding is illustrated
further by the observation that in reverse immunoprecipitation
experiments, we could not detect the interaction between species 7
E7 proteins and p190 (data not shown). What is also intriguing is
the observation that species 7 E7 oncoproteins contain glutamine
or glutamate (Q or E) at the position corresponding to residue 66
in HPV16 (Fig. 4B). An arginine (R) at this position is perfectly
conserved across all other tested E7 proteins and was also one of
the two residues identified as important for p190 binding in
HPV16 (Fig. 3A and B). Overall, these experiments illustrate that
p190 is an evolutionarily conserved target of E7 proteins of multiple HPV species and likely represents an important target for an
efficient HPV life cycle.
Expression of HPV16 E7 reduces stress fiber formation. It has
been well established that organization of actin filaments is controlled by the Rho family members (Rho, Rac, and Cdc42) (40,
41). In particular, RhoA regulates the assembly of actin stress fibers and focal contacts through activation of the downstream effectors mDia and ROCK kinase, while Cdc42 and Rac1 stimulate
the formation of filopodia and lamellipodia, respectively, in migrating cells (42–45). It was previously shown in two independent
publications that HPV16 E7- and HPV38 E7-expressing keratinocytes both contain reduced RhoA-GTP levels. The HPV16 E7 reduction in RhoA-GTP was shown to be due in part to E7 modulation of the cytoplasmic localization of p27, which can in turn
bind and dysregulate RhoA (46). On the other hand, HPV38 E7
uses two distinct mechanisms to downregulate Rho activity: (i)
mediating the activation of the CK2–MEK– extracellular signalregulated kinase (ERK) pathway and (ii) directly binding to eukaryotic elongation factor 1A (eEF1A) and abolishing its effects on
actin fiber formation (47). Due in part to these published observations and considering that p190 is a direct regulator of the Rho
pathway, we wanted to assess the biological consequences of E7p190 interaction. Attenuation of the RhoA pathway leads to a
decrease in both actin stress fibers and focal adhesion formation
(25). Therefore, we compared the status of stress fibers in cells
expressing HPV16 E7 to those of control, GFP-expressing cells
and cell expressing dominant negative p190 (p190RA). For the
purposes of these functional assays, we utilized human osteosarcoma U2OS cells, since they were previously utilized for similar
assays and were shown to behave similarly to human keratinocytes
in these experiments (47). In addition, we also confirmed the results of these assays in human keratinocyte HaCat cells. U2OS or
HaCat cells transfected with GFP or the indicated E7 construct
were stained with Alexa 568-conjugated phalloidin to visualize
F-actin. This staining revealed that control cells expressing GFP
contained more actin stress fibers than did wild-type E7-expressing cells (Fig. 5C). In U2OS cells, the actin stress fibers were more
frequently present throughout the cytoplasm of GFP cells, while
such an organization was more frequently missing or altered in
wild-type E7 cells. In those cells, F-actin was localized mainly at
FIG 5 Interaction with p190 is required for HPV16 E7 to disrupt actin stress
fiber formation. (A) Dominant negative p190 disrupts actin stress fibers.
U2OS cells were transfected with GFP or GFP-p190RA (dominant negative
p190) and then stained with phalloidin-Alexa 568 to visualize F-actin. The
nuclei were stained with DAPI, and images were acquired on a confocal microscope. (B) Quantification of phalloidin intensities in GFP- and p190RAexpressing U2OS or HaCat cells. Data are representative results from three
independent experiments. (C) HPV16 E7 mutants unable to bind p190 do not
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efficiently disrupt actin stress fibers. U2OS cells were transfected with the indicated plasmids and stained for F-actin by use of phalloidin-Alexa 568. Nuclei
were stained with DAPI. (D) Quantification of phalloidin staining in transfected U2OS or HaCat cells. Phalloidin intensities were quantified from images
captured with a fluorescence microscope as described in Materials and Methods. Data are representative of three independent experiments.
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FIG 6 E7 affects F-actin levels in stable cell lines. (A) Expression of E7 in
U2OS-neo and U2OS-E7 cells. Equal amounts of cell extracts from U2OS-neo
and U2OS-E7 cells were analyzed by immunoblotting as indicated. (B) U2OSneo and U2OS-E7 cells were stained with phalloidin-Alexa 568 to visualize
F-actin. The nuclei were stained with DAPI, and images were acquired on a
confocal microscope. (C) Quantification of phalloidin intensities in U2OSneo and U2OS-E7 cells. Data are representative results from three independent
experiments.

the periphery of the cells, in a cortical pattern (Fig. 5C). The phenotype observed in E7-expressing cells was similarly observed in
cells expressing dominant negative p190 (Fig. 5A). Quantification
of the actin stress fiber loss is presented in Fig. 5B and D, with
statistically significant reductions observed in E7- and p190RAexpressing cells. In addition, a U2OS cell line stably expressing E7
(35) also displayed a significant disruption of actin stress fibers
compared to the matched U2OS-neo control cell line (Fig. 6).
To assess the contribution of the E7-p190 interaction to the
observed F-actin phenotype, we transfected U2OS cells with
GFP-E7 V55T or R66E, the two mutants of E7 which did not bind
p190, and assessed the levels of F-actin by staining the cells with
phalloidin. We found that both V55T and R66E mutant-expressing cells had more stress fibers than wild-type E7 cells, with quantified phalloidin levels resembling those in the cells expressing
GFP only (Fig. 5C and D). Overall, these data strongly suggest that
expressed E7 phenotypically acts like dominant negative p190 and
that association of E7 with p190 dysregulates this GAP and contributes to reduced F-actin levels.
The association of E7 with p190 influences cell spreading.
p190 was previously shown to play a crucial role in early events
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during cell spreading on fibronectin (28). Precise temporal regulation of RhoA by p190 upon cell adhesion to the extracellular
matrix protein fibronectin is required for efficient cell spreading
(28). As an additional confirmation of the biological significance
of E7-p190 interaction, we assessed whether expression of E7 has
any effects on cell spreading. We transfected U2OS or HaCat cells
with GFP, wild-type E7 or the indicated E7 mutant, and dominant
negative p190 and determined the areas of cell spreading on fibronectin-coated coverslips. Spreading was assessed 20 min after
plating, as this was the time point at which control cells were well
spread and at which p190 was previously shown to be essential in
efficient cell spreading (28). We found that cells expressing wildtype E7, similarly to cells expressing the dominant negative p190
mutant, had a significantly decreased ability to spread. However,
the two mutants of E7 which could not bind p190 (V55T and
R66E) did not exhibit this effect (Fig. 7A and B). Interestingly,
reduced cell spreading upon expression of dominant negative
p190 was also observed in the HPV16-positive CaSki cells (Fig.
7B).
We also illustrated that the effects on cell spreading appear to
be specific to the E7-p190 interaction by assessing the ability of
additional mutants of E7 to spread. The C59S mutant is a mutant
of E7 which binds p190 comparably to wild-type E7; when we
tested it for effects on spreading, we found that it behaved like
wild-type E7 (Fig. 8A and B). Since V55T and R66E mutants were
previously shown to also have defects in the ability to bind the
cullin 2 E3 ubiquitin ligase, we wanted to ascertain that the effects
on cell spreading were due only to defects in p190 binding. In
addition to the V55T and R66E mutants, N53D and T72D mutants were also previously shown to have reduced cullin 2 binding
(33); however, the N53D and T72D mutants maintain wild-type
p190 binding. When they were assessed in the cell spreading assay,
the N53D and T72D mutants behaved like wild-type E7, demonstrating that the effects of E7 on cell spreading did not require
interaction with cullin 2 and that only mutants with defects in
p190 binding were impaired (Fig. 8A and C). These effects were
not due to differences in expression levels, as all mutants of interest were expressed as well as wild-type E7 (Fig. 8D).
Expression of E7 or dominant negative p190 has the same
effect on RhoA-GTP. U2OS cells were transfected with GFP or
wild-type E7, and cell lysates were analyzed for RhoA-GTP levels,
similarly to previously described studies (28). Transfections with
dominant negative p190 or wild-type p190 were used as controls.
As previously reported (28), expression of wild-type p190 led to
significantly decreased RhoA-GTP levels, whereas expression of
dominant negative p190 had no effect on RhoA-GTP (Fig. 9A).
Interestingly, in this assay the effects of wild-type E7 on RhoAGTP were once again similar to those of dominant negative p190
(Fig. 9A). In addition, we also found that expression of E7 did not
lead to changes in tyrosine phosphorylation of p190 (Fig. 9B).
Together, these data further suggest that E7 has effects on p190
similar to those observed upon expression of dominant negative
p190 and that E7 likely dysregulates p190.
DISCUSSION

Many pathogens, including viruses, have evolved gene products to
engage and subvert the actin cytoskeleton and, in particular, the
Rho family GTPase signaling system (48–50). The actin cytoskeleton is highly dynamic and is manipulated primarily by members
of the Rho family GTPases that control signal transduction path-

Journal of Virology

Downloaded from https://journals.asm.org/journal/jvi on 22 June 2022 by 207.136.114.76.

Todorovic et al.

HPV E7 Interacts with p190RhoGAP

ways linking membrane receptors to the cytoskeleton. Rho family
GTPases regulate numerous cellular processes, including F-actin
polymerization, cell polarity, migration, spreading, and cell
growth. Among the known Rho family GTPases, RhoA is responsible for the regulation of stress fiber formation. Rous sarcoma
virus, simian virus 40 (SV40), polyomaviruses, adenoviruses, and
HPVs have all been shown to encode viral gene products which
manipulate the Rho family GTPase signaling pathway (46, 51–54).
Of particular relevance for this report is the observation that the
cutaneous betaherpesvirus HPV38 E7 protein affects actin stress
fiber formation (47). Disruption of actin stress fibers was shown to
be dependent on inhibition of RhoA activity (47). In addition, E7
of mucosal high-risk HPV16 has been implicated in dysregulating
both RhoA and Rac1 GTPases (46, 54). The possible contribution
and importance of the RhoA pathway in high-risk HPV-induced
transformation are illustrated by recent findings that primary human keratinocytes can be immortalized effectively by treatment
with a Rho kinase inhibitor (Y27632) and that this can substitute
for E7 (55, 56). Interestingly, recent studies have implicated the
cytoskeleton as being critical not only for processes such as migration and spreading but also for cell growth. Many cytoskeletal
components and the elements of the Rho signaling pathway were
discovered to play a central but largely complex role in control of
cell proliferation (57).
In this report, we show that HPV16 E7 interacts with a potent
regulator of RhoA, the p190RhoGAP protein. Interestingly, a re-
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cent study using mass spectrometry identified 1,079 cellular proteins targeted by various tumor virus oncoproteins; in that study,
p190 was also identified as a potential target of HPV16 E7 (58).
Interactions between another Rho GAP (p50RhoGAP) and SV40
small T antigen or Epstein-Barr virus (EBV) BFLF2 and BGLF3
were also identified in that study, suggesting that multiple tumor
viruses target Rho during infection. We show that E7 binds p190
under endogenous conditions in HPV16-positive cervical cancer
cells. We carried out extensive mapping studies, and we show that
E7 proteins of diverse species and types, including high- and lowrisk types, all bind p190, suggesting that p190 is an important
target of E7. In another recent study which also utilized mass
spectrometry to identify novel and unique interacting partners of
a large number of HPV E7 proteins from different HPV types and
which also included representatives of species 7, 9, and 10, only a
few cellular proteins were found to be highly conserved targets of
E7 (59). These included the pocket proteins pRb and p130, which
are essential for control of the cell cycle and are also dysregulated
by E7, as well as a 600-kDa E3 ubiquitin ligase, p600, whose role in
E7 transformation and the HPV life cycle remains largely unknown (59). Our finding that E7-p190 interaction is highly conserved suggests that p190 is a crucial target of E7 in the HPV life
cycle and perhaps could contribute to E7-induced transformation.
In addition, our mapping experiments highlight the importance of residue R66 (HPV16) for p190 interaction; we identified
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FIG 7 E7 affects cell spreading. (A) U2OS cells were transiently transfected with GFP or GFP fusions of wild-type, V55T, or R66E E7 or dominant negative p190
(p190RA), plated on fibronectin for 20 min, and then stained for F-actin by use of phalloidin. Images were captured with a fluorescence microscope using a ⫻40
objective; representative images are shown. (B) The relative areas of individual U2OS, HaCat, and CaSki cells (transfected as indicated and processed as described
for panel A) in digital images were measured with ImageJ. Data are representative of at least 75 cells and three independent experiments.
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FIG 8 The ability of E7 to associate with p190, but not cullin 2, appears to be
necessary to reduce cell spreading. (A) p190 and cullin 2 (cul2) binding phenotypes of the mutants used in this study. The N53D, C59S, and T72D mutants
bound p190 as well as wild-type E7 (⫹⫹); the S63D mutant had reduced p190
binding (⫹). The C59S mutant bound cul2 comparably to the wild type (⫹⫹),
whereas the N53D, S63D, and T72D mutants all had reduced cul2 binding
(⫹). (B) U2OS cells were transiently transfected with GFP or GFP fusions of
wild-type, C59S, or S63D E7, plated on fibronectin for 20 min, and then
stained for F-actin by use of phalloidin. Images were captured with a fluorescence microscope using a ⫻40 objective. The relative areas of individual cells
in digital images were measured with ImageJ. Data are representative of at least
75 cells and two independent experiments. (C) U2OS cells were transiently
transfected as indicated and processed as described for panel B. (D) U2OS cells
were transfected with wild-type E7 or the indicated E7 mutant. At 24 h posttransfection, cell lysates were examined for E7 expression levels via Western
blotting.
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R66 as a necessary residue for interaction of p190 and HPV16 E7.
When we examined the multiple-sequence alignment of the different HPV E7 proteins used in this report, we noticed that R66 is
highly conserved (Fig. 4B), with the exception of the weakly interacting species 7 members. Members of species 7 do not contain a
basic residue at the position corresponding to R66. A lack of arginine at this position could account for their reduced interaction
with p190. This observation may serve as a potential tool to discriminate between strong and weak E7-p190 interactions in future
studies. In addition to R66, residue V55 in HPV16 E7 was also
necessary for p190 interaction. Our previous work has shown that
R66E and V55T mutants both have a significant increase in the
ability to transform primary baby rat kidney (BRK) cells (32).
How the interaction with p190 influences BRK cell transformation remains an interesting topic to examine in future studies.
Coimmunoprecipitation experiments revealed that E7 CR3 is
necessary and sufficient to interact with p190. Additionally, we
showed that the middle domain of p190 is sufficient to associate
with E7 residues 39 to 98. Interestingly, this region of p190 contains many protein-protein interaction motifs and contains the
major site of tyrosine phosphorylation (Tyr 1105) (37, 60–62).
Among the interactions made by this portion of p190, phosphotyrosine 1105 serves as the major binding site for p120RasGAP
(60). Phosphorylation of Tyr 1105 in p190 by Src family kinases
and other tyrosine kinases results in activation of p190’s RhoGAP
activity, with concomitant inhibition of p120RasGAP activity of
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FIG 9 Effects on RhoA-GTP levels and p190 tyrosine phosphorylation. (A)
Expression of wild-type p190, but not wild-type E7 or dominant negative
p190, affects RhoA-GTP levels. U2OS cells were transfected with GFP, wildtype E7, p190, or dominant negative p190. At 24 h posttransfection, the cells
were trypsinized, kept in suspension for 1 h, and then plated on fibronectincoated tissue culture dishes for 20 min. The cells were collected and analyzed
for RhoA-GTP levels as described in Materials and Methods. There was no
statistical significance between wild-type E7 or p190RA and GFP. (B) E7 does
not affect p190 tyrosine phosphorylation. U2OS cells were transfected with
GFP or E7, and p190 tyrosine phosphorylation was assessed as described in
Materials and Methods.
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Our data strongly suggest that E7 negatively regulates the
RhoGAP activity of p190; however, the mechanism by which this
occurs remains unknown. Many reports in the past have focused
on positive regulation of p190RhoGAP activity by phosphorylation of tyrosine 1105. However, we did not see any effects of E7 on
this modification (Fig. 9B). In contrast to tyrosine phosphorylation, serine/threonine phosphorylation decreases p190 activity
(64, 65). In certain circumstances, p190 activity can also be regulated such that there is an inhibition of RhoGAP and an increase in
RacGAP activity (66, 67). In addition, negative regulation of p190
activity is also achieved by several different phosphatases which
dephosphorylate p190, including protein tyrosine phosphatase 20
(PTP20) and protein tyrosine phosphatase receptor type z (Ptprz)
(68, 69). Future work will focus on determining if any of the
above-mentioned mechanisms are used by E7 to dysregulate p190
and what other effects this interaction may have on the Rho signaling pathways.
In conclusion, we have identified that p190, an upstream negative regulator of RhoA, is an interacting partner of the E7 proteins of multiple HPV types. Our data strongly suggest that p190 is
dysregulated by E7, which leads to changes in the actin cytoskeleton. Our findings also suggest that E7’s dysregulation of p190
influences cell properties which may be crucial for the viral life
cycle, or perhaps for HPV-induced transformation. Most importantly, our work emphasizes the need for further studies in an area
that has been largely unexplored in the HPV field.
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bound p120. This phosphorylation event therefore coregulates
signaling through the Ras and Rho pathways. Targeting of the
middle domain by E7 could potentially have an impact on the
ability of p190 to associate with binding partners, including tyrosine kinases and p120RasGAP. This observation serves as an
intriguing possibility for future study, particularly for elucidating
the mechanism by which E7 dysregulates p190.
As described in previous sections, a recent report has shown
that human keratinocytes expressing HPV16 E7 have reduced
RhoA-GTP levels (46). Additionally, a report examining cutaneous HPV38 E7 has clearly established that E7 reduces RhoA-GTP
levels and downregulates levels of F-actin. Similarly to HPV38 E7
cells, we determined that HPV16 E7-expressing cells also showed
fewer and more disorganized actin stress fibers and had reduced
F-actin levels. However, E7 did not reduce RhoA-GTP levels under the conditions of our experiments (Fig. 9A). In addition, our
results indicate that the E7-p190 interaction may be important for
regulation of F-actin. The significance of E7-p190 interaction first
became apparent when we observed that cells which expressed the
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To further understand the significance of E7-p190 interaction
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early events upon attachment to a substrate (28). Expression of
dominant negative p190 leads to cells which are unable to spread
efficiently (28). We utilized dominant negative p190 as a control
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mutants to spread (Fig. 7 and 8). We determined that cells expressing wild-type E7 behaved similarly to cells expressing dominant negative p190, whereas the V55T and R66E mutants behaved
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(C59S, N53D, and T72D) which maintained wild-type p190 binding ability behaved like wild-type E7 in this assay (Fig. 8). However, any reduction in p190 binding, as illustrated by the E7 S63D
mutant (Fig. 3), could lead to changes in the ability of cells to
spread (Fig. 8). In contrast, the ability of E7 to interact with cullin
2 was not required to affect cell spreading.
We also assessed the effects of E7 on RhoA-GTP levels in an
assay in which the cells were kept in suspension and then plated on
fibronectin-treated plates. Under such conditions, functional
p190 is necessary to effectively decrease RhoA-GTP levels, preventing premature formation of actin stress fibers and allowing
the cells to spread. In this assay, we found that expression of wildtype E7 and dominant negative p190 did not lead to a decrease in
RhoA-GTP levels (Fig. 9A). Together, these experiments further
suggest that E7 binding of p190 leads to dysregulation of this GAP
and also highlight that E7 targeting of p190 has important biological consequences.
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